Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
about
Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma.Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation
P2860
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@en
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@nl
type
label
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@en
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@nl
prefLabel
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@en
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.
@nl
P2093
P2860
P356
P1476
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients
@en
P2093
P2860
P304
P356
10.12659/MSM.894847
P577
2015-11-30T00:00:00Z